Involvement in Chemotherapy Decision Making among Patients with Stage II and III Colon Cancer.
Jessica D AustinElizabeth SheltonDanielle M CrookesAlfred I NeugutRachel C SheltonPublished in: MDM policy & practice (2023)
Shared involvement around chemotherapy decisions remains limited for patients diagnosed with colon cancer.Sociodemographic (age, race, gender), interpersonal (medical mistrust), and intrapersonal (decisional self-efficacy, perception of choice) factors that influence preferred involvement in chemotherapy decision making may differ from those influencing actual involvement in chemotherapy decision making.Shared involvement in chemotherapy decisions may look different than currently conceptualized, notably when uncertainty around the benefits exists.